Kazuma Takase

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models.

Masao Iwata, Kiyoshi Okamoto, Yuji Yamamoto, 2013, Cancer letters.